Pfizer, J&J, Roche, GSK and AstraZeneca
– In a bid to thwart counterfeits, Pfizer is reworking the distribution model for prescription drugs by offering to sell Viagra directly on its Viagra web site with the prescriptions being handled by CVSCaremark, the pharmacy benefits manager. Pharmalot asks Pfizer Sells Viagra To Consumers: Is This A Good Idea? Clearly, this is a novel approach and the implications may be widespread, especially if drugmakers believe this approach can boost business for a variety of medicines
– Johnson & Johnson is looking to bring its brand back to being ‘the best’. AdAge talked with VP of Global Corporate Affairs, Michael Sneed, in J&J Launches Massive Corporate-Image Rebranding Campaign discussing the launch of the global corporate-image campaign “For All You Love”. The campaign was inspired by J&J’s credo, written by founder Robert Wood Johnson, spelling out responsibilities to stakeholders
– San Francisco Business Times’ Roche, QB3 Target Life Sciences Startups in Funding Plan provides an overview of Roche’s involvement with the University of California’s QB3 and Mission Bay Capital to identify, fund and support early-stage life sciences startups in the Bay Area
– As part of its commitment to transparency, GlaxoSmithKline has announced the availability of new online system to share patient level data from its clinical trials with researchers. GSK Announces New Online System to Share Patient Level Data with Researchers from Pharmaceutical Business Review reports the new online system available on gsk.com enables researchers to access the detailed trial data that helps with scientific understanding and patient care improvement
– With oncology as one of AstraZeneca’s core therapy areas and accelerating the development of a number of new molecular entities being a strategic priority, AstraZeneca Issues Update on Accelerated Oncology Pipeline. World Pharma News covers the progress on the three cancer compounds moving forward to Phase III clinical development
